BioDelivery Sciences International, Inc. (NASDAQ:BDSI)
CAPS Rating:
A biopharmaceutical company that is utilizing its licensed, owned and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties.
RSS Headlines
Fool UK
Recs
Beaten down, recent insider buying, solid balance sheet.